- Home
- VIR vs AIO Comparison
VIR vs AIO Comparison
Compare VIR & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- AIO
- Stock Information
- Founded
- VIR 2016
- AIO 2019
- Country
- VIR United States
- AIO United States
- Employees
- VIR N/A
- AIO N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- AIO Finance/Investors Services
- Sector
- VIR Health Care
- AIO Finance
- Exchange
- VIR Nasdaq
- AIO Nasdaq
- Market Cap
- VIR 844.9M
- AIO 808.3M
- IPO Year
- VIR 2019
- AIO N/A
- Fundamental
- Price
- VIR $5.13
- AIO $24.72
- Analyst Decision
- VIR Strong Buy
- AIO
- Analyst Count
- VIR 7
- AIO 0
- Target Price
- VIR $32.86
- AIO N/A
- AVG Volume (30 Days)
- VIR 1.1M
- AIO 141.5K
- Earning Date
- VIR 07-31-2025
- AIO 01-01-0001
- Dividend Yield
- VIR N/A
- AIO 9.05%
- EPS Growth
- VIR N/A
- AIO N/A
- EPS
- VIR N/A
- AIO N/A
- Revenue
- VIR $20,861,000.00
- AIO N/A
- Revenue This Year
- VIR N/A
- AIO N/A
- Revenue Next Year
- VIR N/A
- AIO N/A
- P/E Ratio
- VIR N/A
- AIO N/A
- Revenue Growth
- VIR N/A
- AIO N/A
- 52 Week Low
- VIR $4.32
- AIO $15.09
- 52 Week High
- VIR $14.45
- AIO $20.25
- Technical
- Relative Strength Index (RSI)
- VIR 48.62
- AIO 68.46
- Support Level
- VIR $5.00
- AIO $23.31
- Resistance Level
- VIR $5.35
- AIO $24.94
- Average True Range (ATR)
- VIR 0.24
- AIO 0.38
- MACD
- VIR 0.02
- AIO -0.00
- Stochastic Oscillator
- VIR 31.21
- AIO 90.49
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.